×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
ON DEMAND - What Does THAT Mean? Communicating Study Risks and Benefits in Patient-Friendly Language
Session Chair(s)
Lindsay McNair, MD, MPH, MS
Principal Consultant
Equipoise Consulting, United States
Informed consent involves information, comprehension, and voluntariness. Effective communication requires thoughtful methods beyond “lay language” translation. We will review novel approaches; participants will create ICD risk sections.
Learning Objective : Recognize commonly-used patterns of communicating risk/benefit language that may not be patient-friendly; Demonstrate the synthesis of risk information that would be appropriate for an informed-consent discussion that incorporates best practices in patient-friendly communication.
Speaker(s)
Facilitator
Joan Affleck, MA, MBA
Merck & Co., Inc., United States
Associate Vice President, Head of Medical Writing
Have an account?